BNTC – benitec biopharma inc. (US:NASDAQ)
Stock Stats
News
1/12
12:02 pm
bntc
Low
Benitec Biopharma (NASDAQ:BNTC) had its "buy" rating reaffirmed by analysts at Cowen Inc.
1/11
08:11 am
bntc
Low
Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response [Yahoo! Finance]
1/11
08:00 am
bntc
Low
Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response
12/3
07:02 pm
bntc
Medium
Down 25.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Benitec Biopharma (BNTC) [Yahoo! Finance]
11/24
08:05 am
bntc
Medium
Benitec Biopharma (NASDAQ:BNTC) was given a new $32.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.
11/14/2025
05:00 pm
bntc
3.1%
BEAT
9/22/2025
04:05 pm
bntc
-2.1%
MISS
11/4
07:21 am
Reiterates
Outperform
Outperform
Citigroup Inc.
Low
2.1%
12/29
07:31 pm
bntc
Low
Form 4 Benitec Biopharma Inc. For: Dec 23 Filed by: Averill Madison Master Fund, Ltd.
12/22
07:45 pm
bntc
Low
Form 4 Benitec Biopharma Inc. For: Dec 18 Filed by: Averill Madison Master Fund, Ltd.
12/8
11:44 am
bntc
Low
Form SCHEDULE 13G/A Benitec Biopharma Inc. Filed by: JANUS HENDERSON GROUP PLC
12/3
04:22 pm
bntc
Medium
Form SCHEDULE 13G Benitec Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
12/3
04:21 pm
bntc
Medium
Form 4 Benitec Biopharma Inc. For: Dec 01 Filed by: Mates Sharon
Show more
Top News Gainers
4/20 BENITEC BIOPHAR/S (NASDAQ: BNTC) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating and a $14.00 price target on the stock. 109.0%
4/14 Form 25-NSE Benitec Biopharma LTD/AD Filed by: The Nasdaq Stock Market LLC 33.9%
7/31 ASX/NASDAQ ANNOUNCEMENT Appendix 4C: Quarterly Cash Flow Report 28.8%
3/26 Benitec Announces Results of Scheme Meeting 11.9%
4/17 Form EFFECT Benitec Biopharma LTD/AD 6.6%
10/31 Appendix 4C: Quarterly Cash Flow Report 5.2%
9/16 Benitec Biopharma Provides Update on BB-301 Oculopharyngeal Muscular Dystrophy (OPMD) Program 1.6%
4/27 Form 3 Benitec Biopharma Inc. For: Apr 15 Filed by: SOON-SHIONG PATRICK 1.3%
Top News Decliners
6/6 Update on Oculopharyngeal Muscular Dystrophy Program -34.2%
9/19 Benitec Biopharma to present at Ladenburg Thalmann 2019 Healthcare Conference -14.0%
11/27 ASX/NASDAQ ANNOUNCEMENT: Re-domiciliation to the United States -10.2%
4/3 Form 6-K Benitec Biopharma LTD/AD For: Apr 03 -7.5%
1/31 Appendix 4C: Quarterly Cash Flow Report -6.7%
4/27 Form 3 Benitec Biopharma Inc. For: Apr 15 Filed by: Boston Megan -1.6%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3